SEARCH

SEARCH BY CITATION

References

  • Alio Sanda AK, Jusot JF, Alkassoum B & Collard JM. (2011) Determination of pneumococcal serotypes in meningitis cases in Niger, 2003-2011. Poster presented at the Meningitis and Septicemia in Children and Adults 2011 Conference of the Meningitis Research Foundation, London, 8–9 November, 2011. http://www.meningitis.org/posters
  • Broome CV, Rugh MA & Yada AA et al. (1983) Epidemic group C meningococcal meningitis in Upper Volta, 1979. Bulletin of the World Health Organization61, 325330.
  • Campagne G, Schuchat A, Djibo S, Ousséini A, Cissé L & Chippaux JP (1999) Epidemiology of bacterial meningitis in Niamey, Niger, 1981–1996. Bulletin of the World Health Organization77, 499508.
  • Centers for Disease Control Prevention (2009) Pediatric bacterial meningitis surveillance – African Region, 2002–2008. Morbidity and Mortality Weekly Report58, 493497.
  • Chanteau S, Sidikou F, Djibo S, Moussa A, Mindadou H & Boisier P (2006) Scaling up of PCR-based surveillance of bacterial meningitis in the African meningitis belt: indisputable benefits of multiplex PCR assay in Niger. Transactions of the Royal Society of Tropical Medicine and Hygiene100, 677680.
  • Chen RT & Orenstein WA (1996) Epidemiologic methods in immunization programs. Epidemiologic reviews18, 99117.
  • Collard JM, Maman Z, Abani A et al. (2011) Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup A epidemic in Niger 2009: last wave before the introduction of the serogroup A meningococcal conjugate vaccine?Epidemiology and Infection139, 16561660.
  • Cutts FT, Zaman SM, Enwere G et al. (2005) Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double-blind, placebo-controlled trial. Lancet365, 11391146.
  • Delrieu I, Yaro S, Tamekloé TAS et al. (2011) Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS ONE6, e19513.
  • Gessner BD, Mueller JE & Yaro S (2010) African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults. BMC Infectious Diseases10, 22.
  • Giesecke J (Ed) 2002) Routine surveillance of infectious diseases. in: Modern Infectious Disease Epidemiology. 2nd Ed. Edward Arnold, London, pp. 149.
  • Greenwood B (1999) Meningococcal meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene93, 341353.
  • Hassan-King M, Greenwood BM & Whittle HC (1979) An epidemic of meningococcal infection at Zaria, Northern Nigeria. 3. Meningococcal carriage. Transactions of the Royal Society of Tropical Medicine and Hygiene73, 567573.
  • Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N & Pierce N (2003) A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. New England Journal of Medicine349, 13411348.
  • LaForce MF & Okwo-Bele JM (2011) Eliminating epidemic group A meningococcal meningitis in Africa through a new vaccine. Health Affairs6, 10491057.
  • Lapeyssonnie L (1963) La méningite cérébro-spinale en Afrique (Cerebrospinal meningitis in Africa). Bulletin of the World Health Organization28(Suppl), 3114.
  • Leake JAD, Kone ML, Yada A et al. (2002) Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy. Bulletin of the World Health Organization80, 342349.
  • Leimkugel J, Forgor AA, Gangeux S et al. (2005) An outbreak of serotype 1 Streptococcus pneumoniae meningitis in Northern Ghana with features those are characteristic of Neisseria meningitidis meningitis epidemics. Journal of Infectious Diseases192, 192199.
  • Leimkugel J, Hodgson A, Forgor AA et al. (2007) Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight-year longitudinal study in northern Ghana. PLoS Medicine27, e101.
  • Massenet D, Inrombe J, Mevoula DA & Nicolas P (2009) Serogroup W135 meningococcal meningitis, Northern Cameroon, 2007–2008. Emerging Infectious Diseases15, 340342.
  • Mueller JE & Gessner BD (2010) A hypothetical model for meningococcal meningitis in the African meningitis belt. International Journal of Infectious Diseases15, e553e559.
  • Mueller JE, Yaro S, Njanpop-Lafourcade BM et al. (2011) Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage and immunity. Journal of Infectious Diseases204, 17871795.
  • Nicolas P, Norheim G, Garnotel E, Djibo S & Caugant DA (2005) Molecular epidemiology of Neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. Journal of Clinical Microbiology43, 51295135.
  • Njanpop Lafourcade BM, Sanou O, Van der Linden M et al. (2010) Serotyping pneumococcal meningitis cases in the African meningitis belt using multiplex PCR on cerebrospinal fluid. Journal of Clinical Microbiology48, 612614.
  • Paireau J, Girond F, Collard JM, Maïnassara HB & Jusot JF (2012) Analysing spatio-temporal clustering of meningococcal meningitis outbreaks in Niger reveals opportunities for improved disease control. PLoS Neglected Tropical Diseases6, e1577.
  • Parent du Chatelet I, Traoré Y, Gessner BD et al. (2005) Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clinical Infectious Diseases40, 1725.
  • Roberts L (2010) Vaccine introduction. The beginning of the end for Africa’s devastating meningitis outbreaks?Science330, 14661467.
  • Rose AMC, Mueller JE, Gerstl S et al. (2010) Meningitis dipstick rapid test: evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007. PLoS ONE5, e11086.
  • Sidikou F, Djibo S, Taha MK et al. (2003) Polymerase chain reaction assay and bacterial meningitis surveillance in remote areas, Niger. Emerging Infectious Diseases9, 14861488.
  • Sié A, Pflüger V, Coulibaly B et al. (2008) ST-2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study. Tropical Medicine and International Health13, 861868.
  • Soriano-Gabarró M, Toé L & Tiendebeogo SRM et al. (2007) Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003. Vaccine25(Suppl), A92A96.
  • Sow SO, Okoko BJ, Diallo A et al. (2011) Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. New England Journal of Medicine364, 22932304.
  • Tall H, Hugonnet S, Donnen P et al. (2012a) Definition and characterization of localized meningitis epidemics in Burkina Faso. BMC Infectious Diseases12, 2.
  • Tall H, Agbenoko K & Tamekloe ST et al. (2012b) Seasonality of clinical and pneumococcal pneumonia in the African meningitis belt, Togo 2010-2011. Poster presented at the 8th International Symposium on Pneumococci and Pneumococcal Diseases, Iguaçu Falls, Brazil, 11–15 March 2012. Abstract book, 57 (No. 28). http://www2.kenes.com/ISPPD/Scientific/Documents/FinalAbstractbook.pdf
  • Thomson MC, Molesworth AM, Djingarey MH, Tameogo KR, Belanger F & Cuevas LE (2006) Potential of environmental models to predict meningitis epidemics in Africa. Tropical Medicine and International Health11, 781788.
  • World Health Organization (2000) Detecting meningococcal meningitis epidemics in highly-endemic African countries. Weekly Epidemiological Record75, 305312.
  • World Health Organization (2007) Global framework for immunization monitoring and surveillance. http://whqlibdoc.who.int/hq/2007/WHO_IVB_07.06_eng.pdf
  • World Health Organization, Regional Office for Africa (2009) Standard operating procedures for Enhanced Meningitis Surveillance in Africa. http://www.meningvax.org/files/WHO_SOP_EN_2009.pdf
  • World Health Organization, Regional Office for Africa (2011) Meningitis Weekly Bulletin, week 48–52, 2011. http://www.meningvax.com/files/BulletinMeningite2011_S48_52.pdf
  • World Health Organization, Regional Office for Africa (2012) Meningitis Weekly Bulletin, week 14, 2012. http://www.meningvax.com/files/BulletinMeningite2012_S12.pdf